Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Bausch Health Companies

Bausch Health Companies Inc reported $25.44B in Assets for its fiscal quarter ending in March of 2023.

Assets Change
Amgen AMGN:US USD 88.72B 23.6B
ANI Pharmaceuticals ANIP:US USD 765.22M 5.14M
Bausch Health Companies Inc VRX:CN USD 25.44B 241M
Biogen BIIB:US USD 24.6B 44.3M
Catalent CTLT:US USD 11.15B 942M
Corcept Therapeutics CORT:US USD 617.85M 34.42M
Danaher DHR:US USD 85.04B 690M
Drreddys Laboratories RDY:US INR 321.85B 12.55B
Eli Lilly LLY:US USD 53.16B 3.67B
Endo International ENDP:US USD 5.57B 191.83M
Gilead Sciences GILD:US USD 61.88B 1.3B
Horizon Pharma HZNP:US USD 8.99B 121.17M
Nektar Therapeutics NKTR:US USD 561.74M 148.86M
Pacira PCRX:US USD 1.52B 157.78M
Perrigo PRGO:US USD 10.95B 62.4M
Phibro Animal Health PAHC:US USD 965.43M 3.6M
Prestige Brands PBH:US USD 3.35B 396.04M
Revance Therapeutics RVNC:US USD 547.8M 34.1M
Supernus Pharmaceuticals SUPN:US USD 1.79B 89.3M
Vertex Pharmaceuticals VRTX:US USD 18.97B 823.3M
Zoetis ZTS:US USD 13.75B 1.17B